Publications

  1. Yamada S, Nelson T, Kane G, Martinez-Fernandez A, Crespo-Diaz RJ, Ikeda Y, Terzic C, Terzic A. iPS Cell Intervention Rescues Wall Motion Disparity Achieving Biological Cardiac Resynchronization Post-Infarction. J Physiol. 2013 May 13. [Epub ahead of print] 2315351
    View PubMed
  2. Pack QR, Johnson LL, Barr LM, Daniels SR, Wolter AD, Squires RW, Perez-Terzic CM, Thomas RJ. Improving cardiac rehabilitation attendance and completion through quality improvement activities and a motivational program. J Cardiopulm Rehabil Prev. 2013 May-Jun; 33(3):153-9. 2317716
    View PubMed
  3. Folmes CD, Martinez-Fernandez A, Perales-Clemente E, Li X, McDonald A, Oglesbee D, Hrstka SC, Perez-Terzic C, Terzic A, Nelson TJ. Disease-causing Mitochondrial Heteroplasmy Segregated within Induced Pluripotent Stem Cell Clones Derived from A MELAS Patient. Stem Cells. 2013 Apr 03. [Epub ahead of print] 2314599
    View PubMed
  4. Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A. Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. J Cardiovasc Transl Res. 2013 Feb; 6(1):10-21. Epub 2012 Dec 18. 2290860
    View PubMed
  5. Cortes-Bergoderi M, Lopez-Jimenez F, Herdy AH, Zeballos C, Anchique C, Santibanez C, Burdiat G, Gonzalez G, Gonzalez K, Finizola B, Fernandez R, Paniagua M, Thomas RJ, Gonzalez-Moreno J, Rodriguez-Escudero JP, Perez-Terzic C. Availability and characteristics of cardiovascular rehabilitation programs in South America. J Cardiopulm Rehabil Prev. 2013 Jan-Feb; 33(1):33-41. 2290410
    View PubMed
  6. Perez-Terzic CM. Exercise in cardiovascular diseases. PM R. 2012 Nov; 4(11):867-73. 2285308
    View PubMed
  7. Cortes-Bergoderi M, Thomas RJ, Albuquerque FN, Batsis JA, Burdiat G, Perez-Terzic C, Trejo-Gutierrez J, Lopez-Jimenez F. Validity of cardiovascular risk prediction models in Latin America and among Hispanics in the United States of America: a systematic review. Rev Panam Salud Publica. 2012 Aug; 32(2):131-9. 2279680
    View PubMed
  8. Santibanez C, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Araya MV, Burdiat G. [Current status of cardiac rehabilitation in Chile]. Rev Med Chil. 2012 May; 140(5):561-8. 2257686
    View PubMed
  9. Rodriguez-Escudero J, Perez-Terzic C, Allison T. The history of cardiac rehabilitation: a global vision. Avances Cardiol. 2012; 32(1):23-31. 2229760
  10. Santibanez C, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Araya MV, Burdiat G. Current situation of cardiac rehabilitation in Chile. Revista Médica de Chile. 2012; 140(5). 2254181
  11. Anchique CV, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M. Estado actual de la rehabilitacion cardiovascular en Colombia (2010). Revista Colombiana de Cardiologia. 2011 Nov-Dec; 18(6):305. 2222850
  12. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011 Aug 3; 14(2):264-71. 2180627
    View PubMed
  13. Mola A, Perez-Terzic C, Thomas R, Rey M. Cardiovascular disparities: bridging cardiovascular health promotion. US Cardiology. 2011; 8(1):19-23. 2256253
  14. Burdiat G, Perez-Terzic C, Lopez-Jimenez F, Cortes-Bergoderi M, Santibanez C. Current situation of cardiac rehabilitation in Uruguay. Rev Urug Cardiol. 2011; 26:8-15. 2266054
  15. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010 Aug 24; 56(9):721-34. 2111519
    View PubMed
  16. Terzic A, Perez-Terzic C. Channelopathies: decoding disease pathogenesis. Sci Transl Med. 2010 Jul 28; 2(42):42ps37. 2109320
    View PubMed
  17. Faustino RS, Chiriac A, Niederlander NJ, Nelson TJ, Behfar A, Mishra PK, Macura S, Michalak M, Terzic A, Perez-Terzic C. Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype. Stem Cells. 2010 Jul; 28(7):1281-91. 2002044
    View PubMed
  18. Goel K, Shen J, Wolter AD, Beck KM, Leth SE, Thomas RJ, Squires RW, Perez-Terzic CM. Prevalence of musculoskeletal and balance disorders in patients enrolled in phase II cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2010 Jul-Aug; 30(4):235-9. 2305599
    View PubMed
  19. Nelson TJ, Martinez-Fernandez A, Yamada S, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cells: advances to applications. Stem Cells Cloning. 2010 Jan 1; 3:29-37. 2136154
    View PubMed
  20. Gersh BJ, Simari RD, Behfar A, Terzic CM, Terzic A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009 Oct; 84(10):876-92. 1965309
    View PubMed
  21. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res. 2009 Sep 25; 105(7):648-56. Epub 2009 Aug 20. 1959286
    View PubMed
  22. Korenfeld Y, Mendoza-Bastidas C, Saavedra L, Montero-Gomez A, Perez-Terzic C, Thomas RJ, Sert-Kuniyoshi F, Vallejos J, Ibanez-Arenas R, Lopez-Jimenez F. Current status of cardiac rehabilitation in Latin America and the Caribbean. Am Heart J. 2009 Sep; 158(3):480-7. Epub 2009 Aug 04. 1959272
    View PubMed
  23. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009 Aug 4; 120(5):408-16. Epub 2009 Jul 20. 1956990
    View PubMed
  24. Behfar A, Faustino RS, Arrell DK, Dzeja PP, Perez-Terzic C, Terzic A. Guided stem cell cardiopoiesis: discovery and translation. J Mol Cell Cardiol. 2008 Oct; 45(4):523-9. Epub 2008 Sep 26. 1915573
    View PubMed
  25. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells. 2008 Oct; 26(10):2644-53. Epub 2008 Jul 31. 1915759
    View PubMed
  26. Baker DJ, Perez-Terzic C, Jin F, Pitel KS, Niederlander NJ, Jeganathan K, Yamada S, Reyes S, Rowe L, Hiddinga HJ, Eberhardt NL, Terzic A, van Deursen JM. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol. 2008 Jul; 10(7):825-36. Epub 2008 May 30. 2106819
    View PubMed
  27. Park S, Lim BB, Perez-Terzic C, Mer G, Terzic A. Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity. J Proteome Res. 2008 Apr; 7(4):1721-8. Epub 2008 Mar 01. 1885185
    View PubMed
  28. Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008; 9(1):R6. Epub 2008 Jan 09. 1915965
    View PubMed
  29. Arrell DK, Niederlander NJ, Perez-Terzic C, Chung S, Behfar A, Terzic A. Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Clin Pharmacol Ther. 2007 Sep; 82(3):316-9. Epub 2007 Aug 01. 1839128
    View PubMed
  30. Faustino RS, Nelson TJ, Terzic A, Perez-Terzic C. Nuclear transport: target for therapy. Clin Pharmacol Ther. 2007 Jun; 81(6):880-6. Epub 2007 Apr 18. 1824630
    View PubMed
  31. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007 Feb 19; 204(2):405-20. Epub 2007 Feb 05. 1810475
    View PubMed
  32. Perez-Terzic C, Faustino RS, Boorsma BJ, Arrell DK, Niederlander NJ, Behfar A, Terzic A. Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S68-76. 1815180
    View PubMed
  33. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S60-7. 1815181
    View PubMed
  34. Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A, van Deursen JM. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol. 2006 Feb 13; 172(4):529-40. 1750484
    View PubMed
  35. Behfar A, Hodgson DM, Zingman LV, Perez-Terzic C, Yamada S, Kane GC, Alekseev AE, Puceat M, Terzic A. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair. Ann N Y Acad Sci. 2005 May; 1049:189-98. 1743674
    View PubMed
  36. Kane GC, Behfar A, Yamada S, Perez-Terzic C, O'Cochlain F, Reyes S, Dzeja PP, Miki T, Seino S, Terzic A. ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes. 2004 Dec; 53 Suppl 3:S169-75. 1772363
    View PubMed
  37. O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet. 2004 Oct 15; 13(20):2505-18. Epub 2004 Aug 18. 2305611
    View PubMed
  38. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez-Terzic C, Alekseev AE, Puceat M, Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol. 2004 Aug; 287(2):H471-9. 1657336
    View PubMed
  39. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, Badger JD 2nd, Terzic A, Estevez A, Windebank AJ, Dyer RB, Yao J, McMurray CT. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12171-6. Epub 2003 Oct 03. 1422289
    View PubMed
  40. Hodgson DM, Zingman LV, Kane GC, Perez-Terzic C, Bienengraeber M, Ozcan C, Gumina RJ, Pucar D, O'Coclain F, Mann DL, Alekseev AE, Terzic A. Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance. EMBO J. 2003 Apr 15; 22(8):1732-42. 1340445
    View PubMed
  41. Perez-Terzic C, Behfar A, Mery A, van Deursen JMA, Terzic A, Puceat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res. 2003 Mar 7; 92(4):444-52. 1319058
    View PubMed
  42. Mery A, Papadimou E, Zeineddine D, Menard C, Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Perez-Terzic C, Terzic A, Puceat M. Commitment of embryonic stem cells toward a cardiac lineage: molecular mechanisms and evidence for a promising therapeutic approach for heart failure. J Muscle Res Cell Motil. 2003; 24(4-6):269-74. 1417026
    View PubMed
  43. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A. 2002 Oct 1; 99(20):13278-83. Epub 2002 Sep 23. 1316312
    View PubMed
  44. Dzeja PP, Bortolon R, Perez-Terzic C, Holmuhamedov EL, Terzic A. Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer. Proc Natl Acad Sci U S A. 2002 Jul 23; 99(15):10156-61. Epub 2002 Jul 15. 1314981
    View PubMed
  45. Li J, Puceat M, Perez-Terzic C, Mery A, Nakamura K, Michalak M, Krause KH, Jaconi ME. Calreticulin reveals a critical Ca(2+) checkpoint in cardiac myofibrillogenesis. J Cell Biol. 2002 Jul 08; 158(1):103-13. 2114980
    View PubMed
  46. Khurana VG, Perez-Terzic CM, Petersen RC, Krauss WE. Singing paraplegia: a distinctive manifestation of a spinal dural arteriovenous fistula. Neurology. 2002 Apr 23; 58(8):1279-81. 1315596
    View PubMed
  47. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Directed inhibition of nuclear import in cellular hypertrophy. J Biol Chem. 2001 Jun 8; 276(23):20566-71. Epub 2001 Mar 30. 1005220
    View PubMed
  48. Perez-Terzic C, Gacy AM, Bortolon R, Dzeja PP, Puceat M, Jaconi M, Prendergast FG, Terzic A. Structural plasticity of the cardiac nuclear pore complex in response to regulators of nuclear import. Circ Res. 1999 Jun 11; 84(11):1292-301. 117165
    View PubMed
  49. Perez-Terzic C, Jaconi M, Stehno-Bittel L. Measurement of intracellular calcium concentration using confocal microscopy. Methods Mol Biol. 1999; 114:75-91. 1827816
    View PubMed
  50. Perez-Terzic C, Jaconi M, Clapham DE. Nuclear calcium and the regulation of the nuclear pore complex. Bioessays. 1997 Sep; 19(9):787-92. 1827805
    View PubMed
  51. Perez-Terzic C, Stehno-Bittel L, Clapham DE. Nucleoplasmic and cytoplasmic differences in the fluorescence properties of the calcium indicator Fluo-3. Cell Calcium. 1997 Apr; 21(4):275-82. 1827806
    View PubMed
  52. Perez-Terzic C, Pyle J, Jaconi M, Stehno-Bittel L, Clapham DE. Conformational states of the nuclear pore complex induced by depletion of nuclear Ca2+ stores. Science. 1996 Sep 27; 273(5283):1875-7. 1025387
    View PubMed
  53. Stehno-Bittel L, Krapivinsky G, Krapivinsky L, Perez-Terzic C, Clapham DE. The G protein beta-gamma subunit transduces the muscarinic receptor signal for Ca2+ release in xenopus oocytes. J Biol Chem. 1995 Dec 15; 270(50):30068-74. 1022278
    View PubMed
  54. Stehno-Bittel L, Perez-Terzic C, Clapham DE. Diffusion across the nuclear envelope inhibited by depletion of the nuclear Ca2+ store. Science. 1995 Dec 15; 270(5243):1835-8. 1022282
    View PubMed
  55. Perez-Terzic CM, Chini EN, Shen SS, Dousa TP, Clapham DE. Ca2+ release triggered by nicotinate adenine dinucleotide phosphate in intact sea urchin eggs. Biochem J. 1995 Dec 15; 312 ( Pt 3):955-9. 91068
    View PubMed
  56. Lopez JR, Perez C, Linares N, Allen P, Terzic A. Hypersensitive response of malignant hyperthermia-susceptible skeletal muscle to inositol 1,4,5-triphosphate induced release of calcium. Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct; 352(4):442-6. 103176
    View PubMed
  57. Lopez JR, Perez C, Alfonzo M, Cordoves G, Linares N, Allen P. Changes in intracellular calcium concentration induced byinositol 1, 4, 5 triphosphate in human malignant hyperthermia skeletal muscle. Life Science Adv. 1994; 12:131-40. 1827770
  58. Lopez JR, Perez C, Allen P. Abnormal calcium release induced by inositol 1, 4, 5 triphosphate in malignant hyperthermia skeletal muscle. Minerva Anestiologica. 1994; 60:141-4. 1827771
  59. Lopez JR, Perez C, Alfonzo M, Linares N, Cordoves G, Allen P. Probable partecipazione dell'inosilolo 1, 4, 5 trisfosfato nella fisiopatologia dell'ipertermia maligna. Acta Anaesthesiologica Italica. 1993; 44:293-302. 1827763
  60. Lopez JR, Perez C, Allen P, Alfonzo M, Linares N. Efecto del inositol 1, 4, 5 trisfosfato sobre la concentration de calcio en musculo esqueletico de sujetos susceptibles al sindrome de hipertermia maligna. Rev Arg Anes. 1992; 50:193-200. 1827753